Exon

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with axon, the projection of a neuron, or Exxon, a brand of fuel sold by ExxonMobil.
For other uses, see Exon (disambiguation).

An exon is any nucleotide sequence encoded by a gene that remains present within the final mature RNA product of that gene after introns have been removed by RNA splicing. The term exon refers to both the DNA sequence within a gene and to the corresponding sequence in RNA transcripts. In RNA splicing, introns are removed and exons are covalently joined to one another as part of generating the mature messenger RNA.

History[edit]

The term exon derives from the expressed region and was coined by American biochemist Walter Gilbert in 1978: "The notion of the cistron… must be replaced by that of a transcription unit containing regions which will be lost from the mature messenger – which I suggest we call introns (for intragenic regions) – alternating with regions which will be expressed – exons."[1]

This definition was originally made for protein-coding transcripts that are spliced before being translated. The term later came to include sequences removed from rRNA[2] and tRNA,[3] and it also was used later for RNA molecules originating from different parts of the genome that are then ligated by trans-splicing.[4]

Function[edit]

In many genes, each of the exons contain part of the open reading frame (ORF) that codes for a specific portion of the complete protein. However, the term exon is often misused to refer only to coding sequences for the final protein. This is incorrect, since many noncoding exons are known in human genes.[5][6]

Gene structure.svg

To the right is a diagram of a heterogeneous nuclear RNA (hnRNA), which is an unedited mRNA transcript, or pre-mRNAs. Exons can include both sequences that code for amino acids (red) and untranslated sequences (grey). Stretches of unused sequence called introns (blue) are removed, and the exons are joined together to form the final functional mRNA. The notation 5' and 3' refer to the direction of the DNA template in the chromosome and is used to distinguish between the two untranslated regions (grey).

Some of the exons will be wholly or part of the 5' untranslated region (5' UTR) or the 3' untranslated region (3' UTR) of each transcript. The untranslated regions are important for efficient translation of the transcript and for controlling the rate of translation and half-life of the transcript. Furthermore, transcripts made from the same gene may not have the same exon structure, since parts of the mRNA could be removed by the process of alternative splicing. Some mRNA transcripts have exons with no ORFs and, thus, are sometimes referred to as non-coding RNA.

Exonization is the creation of a new exon, as result of mutations in intronic sequences.[7]

Polycistronic messages have multiple ORFs in one transcript and also have small regions of untranslated sequence between each ORF.

Experimental approaches that utilize exons[edit]

Exon trapping or 'gene trapping' is a molecular biology technique that exploits the existence of the intron-exon splicing to find new genes.[8] The first exon of a 'trapped' gene splices into the exon that is contained in the insertional DNA. This new exon contains the ORF for a reporter gene that can now be expressed using the enhancers that control the target gene. A scientist knows that a new gene has been trapped when the reporter gene is expressed.

Splicing can be experimentally modified so that targeted exons are excluded from mature mRNA transcripts by blocking the access of splice-directing small nuclear ribonucleoprotein particles (snRNPs) to pre-mRNA using Morpholino antisense oligos.[9] This has become a standard technique in developmental biology. Morpholino oligos can also be targeted to prevent molecules that regulate splicing (e.g. splice enhancers, splice suppressors) from binding to pre-mRNA, altering patterns of splicing.

See also[edit]

References[edit]

  1. ^ Gilbert W (February 1978). "Why genes in pieces?". Nature 271 (5645): 501. doi:10.1038/271501a0. PMID 622185. 
  2. ^ Kister KP, Eckert WA (March 1987). "Characterization of an authentic intermediate in the self-splicing process of ribosomal precursor RNA in macronuclei of Tetrahymena thermophila". Nucleic Acids Research 15 (5): 1905–20. doi:10.1093/nar/15.5.1905. PMC 340607. PMID 3645543. 
  3. ^ Valenzuela P, Venegas A, Weinberg F, Bishop R, Rutter WJ (January 1978). "Structure of yeast phenylalanine-tRNA genes: an intervening DNA segment within the region coding for the tRNA". Proceedings of the National Academy of Sciences of the United States of America 75 (1): 190–4. doi:10.1073/pnas.75.1.190. PMC 411211. PMID 343104. 
  4. ^ Liu AY, Van der Ploeg LH, Rijsewijk FA, Borst P (June 1983). "The transposition unit of variant surface glycoprotein gene 118 of Trypanosoma brucei. Presence of repeated elements at its border and absence of promoter-associated sequences". Journal of Molecular Biology 167 (1): 57–75. doi:10.1016/S0022-2836(83)80034-5. PMID 6306255. 
  5. ^ Zhang, MQ (May 1998). "Statistical features of human exons and their flanking regions.". Human Molecular Genetics 7 (5): 919–32. doi:10.1093/hmg/7.5.919. PMID 9536098. 
  6. ^ Zhang, XH; Heller, KA; Hefter, I; Leslie, CS; Chasin, LA (Dec 2003). "Sequence information for the splicing of human pre-mRNA identified by support vector machine classification.". Genome Research 13 (12): 2637–50. PMID 14656968. 
  7. ^ Sorek R (October 2007). "The birth of new exons: mechanisms and evolutionary consequences". RNA 13 (10): 1603–8. doi:10.1261/rna.682507. PMC 1986822. PMID 17709368. 
  8. ^ Duyk, G. M, S. W. Kim, R. M Myers, and D. R Cox. 1990. "Exon Trapping: a Genetic Screen to Identify Candidate Transcribed Sequences in Cloned Mammalian Genomic DNA." Proceedings of the National Academy of Sciences 87 (22): 8995.
  9. ^ Morcos PA (June 2007). "Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos". Biochemical and Biophysical Research Communications 358 (2): 521–7. doi:10.1016/j.bbrc.2007.04.172. PMID 17493584. 

General references[edit]

External links[edit]